# A Study of the Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy Adult Participants After Intake of a Single Dose

> **NCT06908954** · PHASE1 · COMPLETED · sponsor: **Ipsen** · enrollment: 31 (actual)

## Conditions studied

- Hepatic Impairment
- Healthy

## Interventions

- **DRUG:** Palovarotene
- **DRUG:** Palovarotene
- **DRUG:** Palovarotene

## Key facts

- **NCT ID:** NCT06908954
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-14
- **Primary completion:** 2026-02-06
- **Final completion:** 2026-02-06
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06908954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06908954, "A Study of the Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy Adult Participants After Intake of a Single Dose". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06908954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*